Cargando…

Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma

BACKGROUND: Diffuse midline gliomas (DMG) are highly malignant incurable pediatric brain tumors. A lack of effective treatment options highlights the need to investigate novel therapeutic strategies. This includes the use of immunotherapy, which has shown promise in other hard-to-treat tumors. To fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	du Chatinier, Aimée, Meel, Michaël H, Das, Arvid I, Metselaar, Dennis S, Waranecki, Piotr, Bugiani, Marianna, Breur, Marjolein, Simonds, Erin F, Lu, Edbert D, Weiss, William A, Garcia Vallejo, Juan J, Hoving, Eelco W, Phoenix, Timothy N, Hulleman, Esther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210310/ https://www.ncbi.nlm.nih.gov/pubmed/35733514 http://dx.doi.org/10.1093/noajnl/vdac079

Ejemplares similares

AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma
por: Metselaar, Dennis S., et al.
Publicado: (2022)

Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas
por: Wei, Xin, et al.
Publicado: (2021)

Microglia in pediatric brain tumors: The missing link to successful immunotherapy
por: du Chatinier, Aimée, et al.
Publicado: (2023)

MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors
por: Meel, Michaël H, et al.
Publicado: (2020)

ATRT-18. SHH-SUBTYPE ATYPICAL TERATOID/RHABDOID TUMORS ARE SELECTIVELY SENSITIVE TO GEMCITABINE TREATMENT
por: Metselaar, Dennis, et al.
Publicado: (2020)

Corrigendum to: Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
Publicado: (2023)

An efficient method for the transduction of primary pediatric glioma neurospheres
por: Meel, Michaël H., et al.
Publicado: (2018)

Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin
por: Metselaar, Dennis S., et al.
Publicado: (2019)

Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
por: Metselaar, Dennis S., et al.
Publicado: (2021)

RONC-21. IDENTIFICATION OF EPIGENETIC DRUGS AS RADIOSENSITIZERS IN PEDIATRIC HIGH-GRADE GLIOMAS
por: Metselaar, Dennis, et al.
Publicado: (2020)

Comparative drug screening in NUT midline carcinoma
por: Beesley, A H, et al.
Publicado: (2014)

Immunisation with ‘naïve’ syngeneic dendritic cells protects mice from tumour challenge
por: Grimshaw, M J, et al.
Publicado: (2008)

Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma
por: Caers, J, et al.
Publicado: (2008)

Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12
por: Barker, S E, et al.
Publicado: (2007)

Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal
por: Yadak, Rana, et al.
Publicado: (2019)

Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines
por: Lindner, D, et al.
Publicado: (2009)

Single-Cell Landscape of Mouse Islet Allograft and Syngeneic Graft
por: Chen, Pengfei, et al.
Publicado: (2022)

Establishment of a syngeneic orthotopic model of prostate cancer in immunocompetent rats
por: Suzuki, Shugo, et al.
Publicado: (2014)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
por: Regan, Jenna N., et al.
Publicado: (2017)

Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models
por: Nolan, Kyle, et al.
Publicado: (2020)

A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host
por: Simons, Brian W., et al.
Publicado: (2019)

Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma
por: Messinger, Dana, et al.
Publicado: (2022)

The endothelin B (ET(B)) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification
por: Cemazar, M, et al.
Publicado: (2005)

Survival rates of children and young adolescents with CNS tumors improved in the Netherlands since 1990: A population-based study
por: Hoogendijk, Raoull, et al.
Publicado: (2021)

Abstract: Whole Eye Transplantation: Allograft Survival with Tacrolimus Immunosupression and Comparison to Syngeneic Transplantation
por: Chen, Wendy, et al.
Publicado: (2018)

Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice
por: Cheng, Pei-Hsin, et al.
Publicado: (2015)

Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model
por: Lin, Kai-Ti, et al.
Publicado: (2017)

Periodontal Tissue Regeneration Using Syngeneic Adipose‐Derived Stromal Cells in a Mouse Model
por: Lemaitre, Mathieu, et al.
Publicado: (2016)

An automated computational image analysis pipeline for histological grading of cardiac allograft rejection
por: Peyster, Eliot G, et al.
Publicado: (2021)

Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas
por: Keane, Lily, et al.
Publicado: (2021)

Endothelin-1 signaling maintains glial progenitor proliferation in the postnatal subventricular zone
por: Adams, Katrina L., et al.
Publicado: (2020)

DIPG-33. CHARACTERIZING THE NEURO-VASCULAR UNIT IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: El-Khouly, Fatma E, et al.
Publicado: (2020)

IMMUNOCOMPETENCE OF SPLEEN CELLS FROM NEONATALLY THYMECTOMIZED MICE CONFERRED IN VITRO BY A SYNGENEIC THYMUS EXTRACT
por: Trainin, Nathan, et al.
Publicado: (1969)

ACE2 Protein Expression During Childhood, Adolescence, and Early Adulthood
por: Schurink, Bernadette, et al.
Publicado: (2022)

Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology
por: Yin, Ting, et al.
Publicado: (2017)

Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients
por: Izquierdo, Elisa, et al.
Publicado: (2021)

An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect
por: Rahal, Farah, et al.
Publicado: (2022)

STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
por: Zhang, Liang, et al.
Publicado: (2022)

Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time
por: Power, Erica A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c5auqfa7saq28ejegp13tda2d4